Colorectal cancers, whether sporadic or hereditary, are caused by a defined
set of molecular events. The genes and pathways involved in the earliest s
teps of tumorigenesis have crucial functions in the regulation of normal cr
ypt homeostasis. Further insight into these pathways can lead to the develo
pment of useful prognostic indicators, and target preventive and therapeuti
c strategies in the management of colorectal cancer. Mutations in the APC/
beta -catenin/Tcf-4 pathway lead to important changes in stem cell dynamics
, before clinically identifiable lesions appear. Preventive strategies aime
d at reversing these changes or therapeutic interventions targeting cell po
pulations with these alterations should be most efficacious.